A phase II single-blind, randomized, placebo-controlled trial to study the efficacy and safety of Study Drug administered as adjunctive treatment to patients with acquired thrombotic thrombocytopenic purpura.
Our in-house oncology and hematology experts make the complex, simple. PRA's global project management and clinical operations team members have an…
Lung Cancer Awareness Month
Oncology & Hematology Fact Sheet
As a recognized leader in conducting complex, global oncology/hematology trials, PRA has contributed to the approval of 16 important drugs. During…